Antitrust Law Daily Wrap Up, ANTITRUST—N.D. Cal.: $228.5 million settlement approved in 13-year suit against Sutter Health, (Nov 7, 2025)

By Christopher M. Longo, J.D.

The court found the settlement in the long-running suit alleging anticompetitive conduct in the health care services industry in Northern California to be “fair, reasonable, and adequate.”

The federal district court in San Francisco, California has finally approved a $228.5 million class-action settlement resolving antitrust claims against Sutter Health. The class plaintiffs in the over 13-year-old case alleged that Sutter was engaging in anticompetitive conduct in the health care services industry in Northern California in violation of state and federal antitrust laws and California law. The court granted final approval of the settlement agreement and awarded attorney fees, litigation costs, and service awards, finding the settlement to be fair, reasonable, and adequate. The court found that the relief provided to the class—approximately three million individuals and businesses who purchased commercial health insurance from major California insurers—was adequate, concluding that it provided “over fifty-five percent of single damages, exceeding typical settlements,” and that “[t]he risks of trial, appeal delays, and costs support[ed] approval” (Sidibe v. Sutter Health, No. 3:12-cv-04854-LB (N.D. Cal. Nov. 6, 2025)).

The lawsuit, which began in 2012 and spanned over thirteen years, centered on allegations that Sutter Health—a health system that evolved, through mergers and acquisitions, from a single hospital opened in 1923 into an integrated healthcare delivery system operator in Northern California—used its market power to impose supra-competitive prices through restrictive contract terms with insurers. Sutter’s practices allegedly included “all-or-nothing” and “anti-steering” provisions that allegedly forced health plans to include Sutter’s hospitals in their networks, even in competitive markets. This conduct allegedly inflated insurance premiums and co-pays, resulting in alleged damages of $411 million between 2011 and 2020. The class included individuals and businesses in nine California rating areas who paid premiums for health insurance policies from Aetna, Anthem Blue Cross, Blue Shield of California, Health Net, or UnitedHealthcare. The lawsuit alleged (1) unlawful tying under the Sherman Act and California Cartwright Act; (2) monopolization and attempted monopolization; and (3) unlawful business acts or practices.

Litigation, trial, and settlement. The case involved extensive discovery, including “over 2.5 million documents from parties, nonparty health plans, and third parties and 155 depositions over 223 deposition days,” as well as substantial expert discovery, involving three experts for the plaintiffs and seven for Sutter. After four amended complaints, motions to dismiss, two rounds of class certification, and three summary judgment motions, the case went to trial. A four-week trial in early 2022 resulted in a verdict for Sutter. However, the Ninth Circuit reversed the decision in June 2024 on two issues: “exclusion of pre-2006 evidence and a revised CACI jury instruction.” The case was remanded for retrial, and the parties reached a settlement in March 2025, just before opening statements. On May 22, 2025, the court preliminarily approved the settlement, and the plaintiffs subsequently moved for final approval of the settlement.

Settlement terms and class definition. The settlement agreement requires Sutter to deposit $228.5 million into a court-approved escrow account within twenty days of the court’s order. The funds will be distributed pro rata to class members. The settlement releases Sutter and its affiliates from any and all claims related to the complaints filed by the plaintiffs, or the alleged anticompetitive conduct. The settlement class is defined as all individuals and entities in the specified nine California rating areas who “paid premiums for a fully insured health insurance policy from Blue Shield, Anthem Blue Cross, Aetna, Health Net or UnitedHealthcare from January 1, 2011 to March 8, 2021.”

Settlement analysis. The court evaluated the settlement under Rule 23(e), considering factors such as adequacy of representation, arm’s-length negotiation, relief provided, and equitable treatment of class members. It found that class counsel and the representatives “litigated vigorously over thirteen years, navigating motions, discovery, trial, and appeals,” and that mediation “ensured a non-collusive process.” The court found the relief to be adequate, as the settlement “provid[es] class members with a recovery of over fifty-five percent of single damages, exceeding typical settlements.” The court found the settlement to be equitable, as pro rata distribution ensures fairness among class members. The court found the settlement to be “fair, adequate, and reasonable.”

Notice and claims administration. The court-approved notice plan was executed by JND, the administrator. Over 6.6 million postcard notices and nearly 2 million email notices were sent. Digital advertising campaigns generated over 1.8 million digital impressions, and a dedicated website provided case details and claim forms. A toll-free line and email support handled thousands of inquiries. By the September 12, 2025, deadline, over 206,000 claims had been filed. Administration costs totaled approximately $10 million, which the court approved.

Attorney fees, costs, and service awards. The court approved attorney fees of $75.4 million, which represented 33 percent of the settlement fund. This amount was supported by “a lodestar cross-check, the complexity and results, and the lack of objections to the settlement amount.” An objection challenging the calculation of fees based on the gross fund was overruled, as “precedent supports gross-fund calculations.” Litigation costs of $28,185,752 were also approved, including $17 million for expert witnesses. Service awards totaling $105,000 were granted to class representatives in recognition of their “significant time and effort during th[e] protracted litigation.”

The Case is No. 3:12-cv-04854-LB.

Judge: Beeler, L.

Attorneys: Azra Z. Mehdi (Mehdi Firm, PC) for Djeneba Sidibe. Oliver Quinn Dunlap (Bartko Pavia LLP) for Sutter Health.

Companies: Sutter Health

Cases: Antitrust CaliforniaNews GCNNews